Trial intelligence / Profile preview

Dexmedetomidine-Assisted Epidural Labor Analgesia and Early Postpartum Depression

ChiCTR2500115774Phase 4Not yet recruiting

Sponsor
Linping District Women and Children Care Hospital
Start
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dexmedetomidine in postpartum depression (PPD), Insomnia and sleep disorder (2 arms), sponsored by Linping District Women and Children Care Hospital. Primary endpoints: PSQS score on the first day after delivery and EPDS score on the 42 days after delivery. Planned start Dec 2025; status: not yet recruiting.

02

Drugs

dexmedetomidine
03

Conditions

postpartum depression (PPD)Insomniasleep disorder

Beyond the preview

Go deeper on ChiCTR2500115774.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500115774.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call